Through an integrative approach that combines classic experimental methodologies with sophisticated bioinformatics analyses, we have ascertained that KIF18B is upregulated in GBM and its expression level increases concomitantly with the advancement of tumor grade. Here, KIF18B is linked to glioblastoma.